Formulation: A crystalline solid

Purity: ≥98%

• Diacylglycerol Kinase Inhibitor I

Formulation: A crystalline solid

Purity: ≥98%

• Diacylglycerol Kinase Inhibitor II
• DKGI-II

Formulation: A 100 mg/ml solution in methyl acetate

Purity: ≥95%

• (±)-1,2-Diolein
• rac-Glycerol 1,2-dioleate

Formulation: A crystalline solid

Purity: ≥95%

• 1,2-DPG
• DG(16:0/16:0/0:0)
• NSC 269964

Formulation: A crystalline solid

Purity: ≥98%

• 1,2-Dioctadecanoyl-sn-glycerol
• DSG

Formulation: A solid

Purity: ≥98%

• 1,2-Dimyristin
• TG(14:0/14:0/0:0)

Formulation: A liquid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

• DG(16:0/0:0/16:0)
• 1,3-Dipalmitin

Formulation: A liquid

Purity: ≥98%

• DG(18:1/0:0/18:1)
• 1,3-Diolein

Formulation: A 10 mg/ml solution in ethanol

Purity: ≥98%

• DG(16:1/0:0/16:1)
• 1,3-Dipalmitolein

Formulation: An oil

Purity: ≥95%

• 16:0/18:1-DG
• DG(16:0/18:1/0:0)
• 1-Palmitin-2-Olein

Formulation: A solid

Purity: ≥98%

• DG(16:0/0:0/18:1)
• 1,3-OP
• 1-Palmitin-3-Olein

Formulation: A neat oil

Purity: ≥95%

• 18:1/16:0-DG
• DG(18:1/16:0/0:0)
• 1,2-OP
• 1-Olein-2-Palmitin

Formulation: A solid

Purity: ≥95%

• DG(18:2/0:0/16:0)
• 1-Linolein-3-Palmitin

Formulation: A solid

Purity: ≥98%

• DG(16:0/0:0/18:0)
• 1-Palmitin-3-Stearin

Formulation: A solid

Purity: ≥98%

• DG(18:0/0:0/18:0)
• 1,3-Distearin
• NSC 404229

Formulation: A yellow lyophilisate

Purity: ≥99%

Formulation: A solid

Purity: ≥98%

• DG(14:0/0:0/14:0)
• 1,3-Dimyristin
• NSC 404226

Formulation: A solid

Purity: ≥98%

• DG(18:0/0:0/18:1)
• 1-Stearin-3-Olein

Formulation: A neat oil

Purity: ≥95%

• DG(8:0/0:0/8:0)
• 1,3-Dioctanoin

Formulation: A 10 mg/ml solution in ethanol

Purity: ≥98%

• DG(22:6/0:0/22:6)
• 1,3-Didocosahexaenoin

Formulation: A liquid

Purity: ≥98%

• Dioleoylglycerol

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

• DG(12:0/12:0/0:0)
• 1,2-Didodecanoyl-rac-glycerol
• 1,2-Dilaurin

Formulation: A liquid

Purity: ≥98%

• Dicaprylin